Genomic and clinicopathological characteristics of low oncotype recurrent score breast cancers with subsequent metastasis
{{output}}
Aims: Oncotype DX has played a critical role in guiding treatment decisions for hormone receptor (HR)-positive, HER2-negative early-stage breast cancer. Clinically, a subset of patients with low Oncotype recurrent score (RS) will... ...
